Reduction of Blood Recirculation in Veno-Venous ECMO

Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Feb 12, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a method to improve blood flow for patients who are on a special treatment called veno-venous ECMO (Extracorporeal Membrane Oxygenation) due to severe breathing problems, specifically a condition known as Acute Respiratory Distress Syndrome (ARDS). In this trial, researchers will measure something called the recirculation fraction (Rf), which is the part of the blood that doesn’t help improve oxygen levels in the body. By using this information, doctors hope to adjust the blood flow in the ECMO machine to make it more effective, while ensuring that patients still get enough oxygen.

To be eligible for the trial, participants need to be at least 18 years old and require veno-venous ECMO for their breathing issues caused by ARDS. Those who join the study can expect to have their blood flow carefully monitored and adjusted based on the measurements taken. The trial is currently recruiting participants, and it aims to find better ways to support patients who are critically ill and need extra help with breathing.

Gender

ALL

Eligibility criteria

• • Patients aged 18 years or older requiring veno-venous ECMO for treatment of refractory hypoxemia in ARDS.